Seeking better outcomes for patients

CytRx Corporation is a biopharmaceutical company focused on the discovery and development of new therapeutics to treat patients with high unmet medical needs

Learn More

CytRx has both near-term potential milestone/royalty payments and a pipeline of additional next-gen candidates ​

CytRx partnered Pipeline ​ with ImmunityBio - Aldoxorubicin​

Potential milestones and royalties from ImmunityBio for aldoxorubicin ​

CytRx milestones and royalties from Orphazyme for Arimoclomol​